United Therapeutics could eventually use the genetically edited swine to grow organs for human transplant recipients. A public biotechnology company is planning a large project in northeast ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq ... strengthen their professional network, aimed at building an inclusive, diverse community.

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq ... organs and organ alternatives, including our plan to submit an IND for a UKidney clinical trial and ...

UBS lowered the firm’s price target on United Therapeutics (UTHR) to $460 from $475 and keeps a Buy rating on the shares. United Therapeutics ...

United Therapeutics (UTHR) announced full enrollment of the TETON 1 study evaluating the use of Tyvaso or treprostinil, inhalation solution or ...